
SEATTLE, Dec. 9 (UPI) -- U.S. cancer researchers say they've found drugs known as statins might protect stem cell transplant patients from graft-versus-host disease.
Fred Hutchinson Cancer Research Center scientists said their retrospective study involved 567 patients who underwent hematopoietic cell transplantation from matched sibling donors between 2001 and 2007. Patients whose donors had been taking statins at the time of stem cell donation were found to have experienced no severe acute graft-versus-host disease.
The disease, a potential side effect of blood-forming stem cell transplants, involves donor immune cells attacking normal patient cells and tissues. About 15 percent of the stem cell donors in the study were taking statins at the time of transplant.
The study's senior author, Dr. Marco Mielcarek, said between 10 percent and 15 percent of transplant patients would normally be expected to develop severe acute graft-versus-host disease.
Mielcarek, Dr. Marcello Rotta and colleagues report their findings in the journal Blood.
|
|
|
| Additional Science News Stories | |
WASHINGTON, Feb. 9 (UPI) --
The United States is trying to get Israel to hold off on a military strike against Iran's nuclear facilities, a U.S. official said.
|
MIAMI, Feb. 9 (UPI) --
Ronnie Smith, former trumpet player for the disco/funk group K.C. and the Sunshine Band, has died in a Florida hospital, his family said.
|
TEMPE, Ariz., Feb. 8 (UPI) --
Neanderthals were not wiped out by modern human ancestors but more likely were integrated into the human gene pool thousands of years ago, U.S. researchers say.
|
UPI horoscopes for Thursday, Feb. 9, 2012.
|
| Stories | Photos | People | Comments |
View Caption